As of September 29, 2026, Medicus Pharma's top three insider holders are Fund Partners, Lp Velocity (TenPercentOwner, 3.25Mn shares), Raza Bokhari (Chief Executive Officer, 2.94Mn shares), Carolyn F. Bonner (President And Cfo, 1.49Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Fund Partners, Lp Velocity | TenPercentOwner | 0 | 3,248,741 | 3,248,741 | 29.3% | 21 May, 2025 |
| 2 | Raza Bokhari | Chief Executive Officer | 2,941,176 | 0 | 2,941,176 | 26.5% | 08 Sep, 2026 |
| 3 | Carolyn F. Bonner | President And Cfo | 1,489,493 | 0 | 1,489,493 | 13.4% | 08 Sep, 2026 |
| 4 | Faisal Mehmud | Chief Medical Officer | 1,470,588 | 0 | 1,470,588 | 13.3% | 08 Sep, 2026 |
| 5 | Andrew Alasdair Smith | Chief Operating Officer | 735,458 | 0 | 735,458 | 6.6% | 08 Sep, 2026 |
| 6 | Edward J. Brennan | Chief Scientific Officer | 674,735 | 0 | 674,735 | 6.1% | 08 Sep, 2026 |
| 7 | James P. Quinlan | Chief Financial Officer | 528,294 | 0 | 528,294 | 4.8% | 14 Aug, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Sep, 2026 | Edward J. Brennan | Chief Scientific Officer | Acquired A | 588,235 | $0.17 | $100.29K | 674,735 | Direct |
| 04 Sep, 2026 | Carolyn F. Bonner | President And Cfo | Acquired A | 1,470,588 | $0.17 | $250.74K | 1,489,493 | Direct |
| 04 Sep, 2026 | Andrew Alasdair Smith | Chief Operating Officer | Acquired A | 735,294 | $0.17 | $125.37K | 735,458 | Direct |
| 04 Sep, 2026 | Faisal Mehmud | Chief Medical Officer | Acquired A | 1,470,588 | $0.17 | $250.74K | 1,470,588 | Direct |
| 04 Sep, 2026 | Raza Bokhari | Chief Executive Officer | Acquired A | 2,941,176 | $0.17 | $501.47K | 2,941,176 | Direct |
| 04 Sep, 2026 | Carolyn F. Bonner | President And Cfo | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 04 Sep, 2026 | Faisal Mehmud | Chief Medical Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 04 Sep, 2026 | Raza Bokhari | Chief Executive Officer | Acquired A | 500,000 | $0.00 | $0 | 500,000 | Direct |
| 04 Sep, 2026 | Edward J. Brennan | Chief Scientific Officer | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 04 Sep, 2026 | Andrew Alasdair Smith | Chief Operating Officer | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 03 Jun, 2026 | William Ashton | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Carolyn F. Bonner | President And Cfo | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 03 Jun, 2026 | Raza Bokhari | Chief Executive Officer | Acquired A | 500,000 | $0.00 | $0 | 500,000 | Direct |
| 03 Jun, 2026 | Patrick J Mahaffy | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Edward J. Brennan | Chief Scientific Officer | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 03 Jun, 2026 | Robert J. Ciaruffoli | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Faisal Mehmud | Chief Medical Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 03 Jun, 2026 | Barry Fishman | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Sara R. May | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Andrew Alasdair Smith | Chief Operating Officer | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |